Value of copeptin and C-reactive protein in acute exacerbation of chronic obstructive pulmonary disease

被引:3
作者
Morsi, Tamer Said [1 ]
Degady, Akram Abd-Elmoneim [2 ]
机构
[1] Alexandria Univ, Fac Med, Chest Dis Dept, Alexandria, Egypt
[2] Alexandria Univ, Fac Med, Clin & Chem Pathol Dept, Alexandria, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2014年 / 63卷 / 04期
关键词
Acute exacerbation; COPD; Copeptin; CRP;
D O I
10.1016/j.ejcdt.2014.07.015
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objectives: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) describes the phenomenon of sudden worsening in airway function and respiratory symptoms in patients with COPD. The aim of this work is to study the value of copeptin and C-reactive protein in AECOPD. Patients and methods: The study enrolled 31 patients with AECOPD and 10 control subjects. All patients were subjected to history taking, clinical examination, arterial blood gases analysis and sputum culture for bacteriological examination. Serum samples were obtained from the patients on admission, 3 days and 14 days after and from control subjects. The samples were analyzed for copeptin and CRP levels. Results: The copeptin level on admission was significantly higher in AECOPD patients than the control subjects. The copeptin and CRP showed a statistically significant decline over the study duration but did not correlate with each other. ROC analysis curve showed that a copeptin level > 14 pg/dl on admission had a sensitivity of 70% and specificity of 90% in predicting AECOPD and a level of > 15 pg/dl on the fourteenth day had a sensitivity of 100% and specificity of 90% in predicting in-hospital mortality. Copeptin correlated significantly directly with the presence of bacterial infection and inversely with both PaO2 and PaCO2. Neither the copeptin nor CRP correlated with the COPD severity as expressed by the FEV1%, BODE index and previous history of exacerbations. Conclusion: Copeptin has a good sensitivity and excellent specificity in predicting AECOPD. Additionally, it has good predilection for short term outcome and in-hospital mortality. (C) 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
引用
收藏
页码:862 / 869
页数:7
相关论文
共 30 条
[1]   Systemic effects of chronic obstructive pulmonary disease [J].
Agustí, AGN ;
Noguera, A ;
Sauleda, J ;
Sala, E ;
Pons, J ;
Busquets, X .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) :347-360
[2]  
Agusti Alvar, 2007, Proc Am Thorac Soc, V4, P522, DOI 10.1513/pats.200701-004FM
[3]  
AKAGI K, 1990, J DEV PHYSIOL, V14, P319
[4]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[5]   EPIDEMIOLOGY AND TREATMENT OF CHRONIC-BRONCHITIS AND ITS EXACERBATIONS [J].
BALL, P .
CHEST, 1995, 108 (02) :S43-S52
[6]   Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Seemungal, TAR ;
Bhowmik, A ;
Wedzicha, JA .
THORAX, 2002, 57 (10) :847-852
[7]  
Elmeligy N., 2010, EUR RESPIR J, V36, pS390
[8]   Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis [J].
Gan, WQ ;
Man, SFP ;
Senthilselvan, A ;
Sin, DD .
THORAX, 2004, 59 (07) :574-580
[9]  
Herrera E A, 2000, High Alt Med Biol, V1, P175, DOI 10.1089/15270290050144172
[10]   Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease [J].
Hurst, JR ;
Perera, WR ;
Wilkinson, TMA ;
Donaldson, GC ;
Wedzicha, JA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (01) :71-78